Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Intuitive Surgical’s Q3 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) said its third-quarter adjusted earnings remained unchanged year-over-year, while revenues increased in double digits.
The top line moved up 11% year-over-year to $1.56 billion during the three-month period, driven by a marked increase in da Vinci procedures and installed bases.
Adjusted earnings remained unchanged at $1.19 per share. Net income, including special items, came in at $324 million or $0.90 per share, compared to $380.5 million or $1.04 per share last year.
Worldwide da Vinci procedures rose approximately 20% year-over-year and the company shipped 305 da Vinci Surgical Systems. At the end of the quarter, it had a total of 7,364 da Vinci Surgical systems installed base, which is up 13%.
Prior Performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
